Navigation Links
Journal Maturitas publishes position statement on management of uterine fibroids
Date:6/16/2014

Amsterdam, June 16, 2014 Journal Maturitas today announced the publication of a position statement by the European Menopause and Andropause Society (EMAS) on the topic of the management of uterine fibroids.

Uterine fibroids (also termed leiomyomas or myomas) are the most common tumors of the female reproductive tract. While they may be asymptomatic they can cause abnormal bleeding, pelvic pressure symptoms and infertility. Fibroid growth and regression vary throughout life. Thus, they tend to grow during the reproductive years and regress after the menopause. They affect millions of women and are the leading cause of hysterectomy.

The traditional management of symptomatic fibroids has been surgery (hysterectomy or myomectomy). However, some women do not want invasive surgery and wish to retain their uterus and fertility. Fortunately, during the last few years new medical and surgical uterine-conserving alternatives have become available as technological advances have been made. The range of medical treatments allows flexible management of fibroid-related symptoms; the options include tranexamic acid, non-steroidal anti-inflammatory drugs, contraceptive steroids, gonadotropin-releasing hormone analogues, antiprogesterone, and selective progesterone receptor modulators. Alternatives to surgery include uterine artery embolization, myolysis and ablation by high-intensity focused ultrasound (guided with magnetic resonance imaging or ultrasound). The choice of treatment depends on fibroid size, the underlying symptoms and their severity and the woman's desire for subsequent fertility and pregnancy, as well as efficacy and need for repeated interventions.


'/>"/>
Contact: Greyling Peoples
g.peoples@elsevier.com
31-204-853-323
Elsevier
Source:Eurekalert

Page: 1

Related medicine news :

1. First articles published in new Journal of Medical Imaging
2. The Academy of Radiology Research featured in Nature Biotechnology journal
3. Opioid overdose prevention programs may reduce deaths, reports Journal of Addiction Medicine
4. SAGE to publish The British Journal of Occupational Therapy
5. Journalism fellowships will increase media spotlight on aging issues
6. ERJ Open Research -- a new society-led open access respiratory journal
7. Clinical opinion published in American Journal of Obstetrics & Gynecology
8. Elsevier and the American Urological Association launch new journal: Urology Practice
9. Journal of Spinal Cord Medicine names Dr. Hwang winner of Ernest Bors, M.D., Award
10. Elsevier announces launch of new open access journal, Schizophrenia Research: Cognition
11. The Lancet journals: World TB Day media alert
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 23, 2017 , ... Catalent Pharma Solutions, the ... and consumer health products, today announced that it had won the ‘Clinical Supply ... the Suntec Singapore International Exhibition & Convention Centre, Singapore. The award was presented ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... and this tool bypasses that. Healthcare facilities across the country are always ... offer their clients and hospitals, across the country, an efficient and quick way ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Rett Syndrome ... devastating neurological disorder that afflicts 350,000 individuals worldwide. Rett Syndrome is caused ... almost exclusively strikes females. Following a normal infancy, Rett Syndrome takes effect ...
(Date:3/22/2017)... ... March 22, 2017 , ... Last year, 43 million gallons of surplus milk ... report. While excess dairy can be caused by several factors, one pharmaceutical company ... inability to properly digest lactose, a sugar found in milk and milk products. ...
(Date:3/22/2017)... Prairie, TX (PRWEB) , ... March 22, 2017 ... ... providing insurance consultation, financial planning, and related services to communities across eastern Texas, ... with the goal of providing meals to hungry children and adults. , ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... , March 22, 2017 TFS is pleased ... Mr. Ed Tumaian , two global executive positions in Medical ... joining the Operational Leadership Team and will report to Dr. ... ... to TFS with 10 years of medical and scientific expertise gained ...
(Date:3/22/2017)... N.Y. , March 22, 2017  As the ... Leukemia & Lymphoma Society (LLS) has played a role ... patients, some of which are even helping patients with ... due to LLS,s significant investment in cutting-edge research – ... milestone continues to grow with the record-breaking sum of ...
(Date:3/22/2017)... NetworkNewsWire Editorial Coverage  ... Deciphering marijuana policy under the Trump ... officials. Federal laws are at odds with a number of ... and businesses like SinglePoint, Inc. (OTC: SING) ( SING Profile ... (OTC: MJNA), Cannabis Science, Inc. (OTC: CBIS) and ChineseInvestors.com, Inc. ...
Breaking Medicine Technology: